Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer By Admin on April 23, 2019 MERCK & CO-FDA/ (URGENT)Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer Original source: https://health.economictimes.indiatimes.com/news/pharma/mercks-keytruda-wins-fda-approval-as-combination-therapy-for-kidney-cancer/68991595?utm_source=RSS&utm_medium=ETRSS Also Read: Natco Pharma founder invests in PURE EV Published in Industry News Health NewsPharma ArticlesPharma News Admin More from Industry NewsMore posts in Industry News »Zydus cuts price of generic remdesivirFrench pharma firm guilty of fraud, manslaughter over weight loss pill: courtEquity indices swing higher, metal and pharma stocks gainFrench pharma giant faces verdict on weight loss pill deaths